Impact of Telestroke Assessments and Treatment with Thrombolytics in the CT-imaging Suite on Door-to-Needle Times (P1-10.004)

Thrombolytic treatment in the CT-imaging suite (CIS) is a Target Stroke best practice, therefore it is hypothesized that taking the Telecart to CT and initiating treatment in CT will reduce door-to-needle (DTN) times.